Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-08 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −1,467 $13.34 $20K 23,787
2026-03-11 Vance Terry Director Grant or award · Stock Option (right to buy) +20,000 20,000
2026-03-11 Russell Lesley Director Grant or award · Stock Option (right to buy) +20,000 20,000
2026-03-11 Peterson Kristine Director Grant or award · Stock Option (right to buy) +20,000 20,000
2026-03-11 Hata Yujiro S Director Grant or award · Stock Option (right to buy) +20,000 20,000
2026-03-11 FOLETTA MARK G Director Grant or award · Stock Option (right to buy) +20,000 20,000
2026-03-11 CARTER BRUCE L A Director Grant or award · Stock Option (right to buy) +20,000 20,000
2026-02-12 Kowalsky Matthew Paul Chief Legal Officer Grant or award +1,318 1,318
2026-02-12 Kowalsky Matthew Paul Chief Legal Officer Grant or award +4,175 5,493
2026-02-12 Kowalsky Matthew Paul Chief Legal Officer Shares withheld for taxes −1,902 $14.25 $27K 3,591
2026-02-12 Luu Brendan Chief Business Officer Grant or award +1,575 39,904
2026-02-12 Luu Brendan Chief Business Officer Grant or award +4,987 44,891
2026-02-12 Luu Brendan Chief Business Officer Shares withheld for taxes −3,257 $14.25 $46K 41,634
2026-02-12 Kieffer Tara Lynn Chief Product Strategy Officer Grant or award +1,575 32,195
2026-02-12 Kieffer Tara Lynn Chief Product Strategy Officer Grant or award +4,987 37,182
2026-02-12 Kieffer Tara Lynn Chief Product Strategy Officer Shares withheld for taxes −3,257 $14.25 $46K 33,925
2026-02-12 Rottinghaus Scott T. Chief Medical Officer Grant or award +1,650 23,442
2026-02-12 Rottinghaus Scott T. Chief Medical Officer Grant or award +5,225 28,667
2026-02-12 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −3,413 $14.25 $49K 25,254
2026-02-12 Or Yat Sun Chief Scientific Officer Grant or award +1,650 373,042

Page 1 of 7 · 135 trades